questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Manifestations neuromusculaires
Manifestations neuromusculaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Myopathies
Biopsie musculaire
Neuropathies
Électromyographie
Tests génétiques
Maladies héréditaires
Force musculaire
Évaluation clinique
Imagerie par résonance magnétique
Anomalies musculaires
Symptômes
5
Dystrophies musculaires
Faiblesse musculaire
Neuropathies périphériques
Douleur neuropathique
Myasthénie
Fatigue musculaire
Sclérose latérale amyotrophique
Difficultés de déglutition
Syndrome de Guillain-Barré
Faiblesse musculaire
Prévention
5
Neuropathies
Prévention des maladies
Crampes musculaires
Hydratation
Myopathies
Diagnostic précoce
Blessures musculaires
Échauffement
Sclérose latérale amyotrophique
Prévention
Traitements
5
Myopathies
Corticostéroïdes
Neuropathies diabétiques
Contrôle glycémique
Myasthénie
Inhibiteurs de l'acétylcholinestérase
Sclérose latérale amyotrophique
Soins palliatifs
Syndrome de Guillain-Barré
Immunoglobulines
Complications
5
Myopathies
Complications respiratoires
Neuropathies
Infections cutanées
Myasthénie
Crises myasthéniques
Sclérose latérale amyotrophique
Paralysie
Syndrome de Guillain-Barré
Complications neurologiques
Facteurs de risque
5
Myopathies
Antécédents familiaux
Neuropathies diabétiques
Diabète
Myasthénie
Maladies auto-immunes
Sclérose latérale amyotrophique
Âge avancé
Syndrome de Guillain-Barré
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Manifestations neuromusculaires : Questions médicales les plus fréquentes",
"headline": "Manifestations neuromusculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Manifestations neuromusculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-13",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurologiques",
"url": "https://questionsmedicales.fr/mesh/D009461",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurologiques",
"code": {
"@type": "MedicalCode",
"code": "D009461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fasciculation",
"alternateName": "Fasciculation",
"url": "https://questionsmedicales.fr/mesh/D005207",
"about": {
"@type": "MedicalCondition",
"name": "Fasciculation",
"code": {
"@type": "MedicalCode",
"code": "D005207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Crampe musculaire",
"alternateName": "Muscle Cramp",
"url": "https://questionsmedicales.fr/mesh/D009120",
"about": {
"@type": "MedicalCondition",
"name": "Crampe musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypertonie musculaire",
"alternateName": "Muscle Hypertonia",
"url": "https://questionsmedicales.fr/mesh/D009122",
"about": {
"@type": "MedicalCondition",
"name": "Hypertonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Raideur musculaire",
"alternateName": "Muscle Rigidity",
"url": "https://questionsmedicales.fr/mesh/D009127",
"about": {
"@type": "MedicalCondition",
"name": "Raideur musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasticité musculaire",
"alternateName": "Muscle Spasticity",
"url": "https://questionsmedicales.fr/mesh/D009128",
"about": {
"@type": "MedicalCondition",
"name": "Spasticité musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009128",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypotonie musculaire",
"alternateName": "Muscle Hypotonia",
"url": "https://questionsmedicales.fr/mesh/D009123",
"about": {
"@type": "MedicalCondition",
"name": "Hypotonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009123",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Faiblesse musculaire",
"alternateName": "Muscle Weakness",
"url": "https://questionsmedicales.fr/mesh/D018908",
"about": {
"@type": "MedicalCondition",
"name": "Faiblesse musculaire",
"code": {
"@type": "MedicalCode",
"code": "D018908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de la tête tombante",
"alternateName": "Dropped Head Syndrome",
"url": "https://questionsmedicales.fr/mesh/D000094222",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de la tête tombante",
"code": {
"@type": "MedicalCode",
"code": "D000094222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Amyotrophie",
"alternateName": "Muscular Atrophy",
"url": "https://questionsmedicales.fr/mesh/D009133",
"about": {
"@type": "MedicalCondition",
"name": "Amyotrophie",
"code": {
"@type": "MedicalCode",
"code": "D009133",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcopénie",
"alternateName": "Sarcopenia",
"url": "https://questionsmedicales.fr/mesh/D055948",
"about": {
"@type": "MedicalCondition",
"name": "Sarcopénie",
"code": {
"@type": "MedicalCode",
"code": "D055948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Myokymie",
"alternateName": "Myokymia",
"url": "https://questionsmedicales.fr/mesh/D020385",
"about": {
"@type": "MedicalCondition",
"name": "Myokymie",
"code": {
"@type": "MedicalCode",
"code": "D020385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myotonie",
"alternateName": "Myotonia",
"url": "https://questionsmedicales.fr/mesh/D009222",
"about": {
"@type": "MedicalCondition",
"name": "Myotonie",
"code": {
"@type": "MedicalCode",
"code": "D009222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasme",
"alternateName": "Spasm",
"url": "https://questionsmedicales.fr/mesh/D013035",
"about": {
"@type": "MedicalCondition",
"name": "Spasme",
"code": {
"@type": "MedicalCode",
"code": "D013035",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Spasme hémifacial",
"alternateName": "Hemifacial Spasm",
"url": "https://questionsmedicales.fr/mesh/D019569",
"about": {
"@type": "MedicalCondition",
"name": "Spasme hémifacial",
"code": {
"@type": "MedicalCode",
"code": "D019569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trismus",
"alternateName": "Trismus",
"url": "https://questionsmedicales.fr/mesh/D014313",
"about": {
"@type": "MedicalCondition",
"name": "Trismus",
"code": {
"@type": "MedicalCode",
"code": "D014313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tétanie",
"alternateName": "Tetany",
"url": "https://questionsmedicales.fr/mesh/D013746",
"about": {
"@type": "MedicalCondition",
"name": "Tétanie",
"code": {
"@type": "MedicalCode",
"code": "D013746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires",
"alternateName": "Neuromuscular Manifestations",
"code": {
"@type": "MedicalCode",
"code": "D020879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael S Cartwright",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Cartwright",
"affiliation": {
"@type": "Organization",
"name": "Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Heinz Jungbluth",
"url": "https://questionsmedicales.fr/author/Heinz%20Jungbluth",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk."
}
},
{
"@type": "Person",
"name": "David Lacomis",
"url": "https://questionsmedicales.fr/author/David%20Lacomis",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Fernandez-Garcia",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Fernandez-Garcia",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "Ruple S Laughlin",
"url": "https://questionsmedicales.fr/author/Ruple%20S%20Laughlin",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personality assessment with Temperament and Character Inventory in Parkinson's disease.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36030666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an Inconsistent Responding Scale for the HEXACO Personality Inventory-Revised.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36859786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911231157620"
}
},
{
"@type": "ScholarlyArticle",
"name": "Construction of item-level scales from the Personality Assessment Inventory to assess levels of personality functioning.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227863",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000628"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of personality disorder in the ICD-11 diagnostic system: Polish validation of the Personality Inventory for ICD-11.",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/37098193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/138563"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item response theory analysis of the University Personality Inventory in medical students.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37366154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/npr2.12362"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Manifestations neuromusculaires",
"item": "https://questionsmedicales.fr/mesh/D020879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Manifestations neuromusculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Manifestations neuromusculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Manifestations neuromusculaires",
"description": "Comment diagnostiquer une myopathie ?\nQuels examens pour les neuropathies ?\nQuel rôle des tests génétiques ?\nComment évaluer la force musculaire ?\nQuand faire une IRM musculaire ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Manifestations neuromusculaires",
"description": "Quels sont les symptômes d'une dystrophie musculaire ?\nComment se manifeste une neuropathie périphérique ?\nQuels signes d'une myasthénie ?\nQuels symptômes d'une sclérose latérale amyotrophique ?\nComment reconnaître un syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Manifestations neuromusculaires",
"description": "Peut-on prévenir les neuropathies ?\nComment prévenir les crampes musculaires ?\nY a-t-il des mesures préventives pour la myopathie ?\nComment éviter les blessures musculaires ?\nPeut-on prévenir la sclérose latérale amyotrophique ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Manifestations neuromusculaires",
"description": "Quels traitements pour la myopathie ?\nComment traiter une neuropathie diabétique ?\nQuel est le traitement de la myasthénie ?\nQuelles options pour la sclérose latérale amyotrophique ?\nComment gérer le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Manifestations neuromusculaires",
"description": "Quelles complications des myopathies ?\nQuels risques avec la neuropathie ?\nQuelles complications de la myasthénie ?\nQuels problèmes liés à la sclérose latérale amyotrophique ?\nQuelles complications du syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Manifestations neuromusculaires",
"description": "Quels facteurs de risque pour les myopathies ?\nQuels risques pour la neuropathie diabétique ?\nQuels facteurs de risque pour la myasthénie ?\nQuels risques pour la sclérose latérale amyotrophique ?\nQuels facteurs de risque pour le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Personality+Inventory#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une myopathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire."
}
},
{
"@type": "Question",
"name": "Quels examens pour les neuropathies ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quel rôle des tests génétiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer la force musculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées."
}
},
{
"@type": "Question",
"name": "Quand faire une IRM musculaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une dystrophie musculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres."
}
},
{
"@type": "Question",
"name": "Quels signes d'une myasthénie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une sclérose latérale amyotrophique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un syndrome de Guillain-Barré ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crampes musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour la myopathie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures musculaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sclérose latérale amyotrophique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la myopathie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie diabétique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la myasthénie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Quelles options pour la sclérose latérale amyotrophique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments pour ralentir la progression et des soins palliatifs."
}
},
{
"@type": "Question",
"name": "Comment gérer le syndrome de Guillain-Barré ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique."
}
},
{
"@type": "Question",
"name": "Quelles complications des myopathies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques."
}
},
{
"@type": "Question",
"name": "Quels risques avec la neuropathie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des blessures dues à une perte de sensation et des infections cutanées."
}
},
{
"@type": "Question",
"name": "Quelles complications de la myasthénie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition."
}
},
{
"@type": "Question",
"name": "Quels problèmes liés à la sclérose latérale amyotrophique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections."
}
},
{
"@type": "Question",
"name": "Quelles complications du syndrome de Guillain-Barré ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les myopathies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels risques pour la neuropathie diabétique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la myasthénie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels risques pour la sclérose latérale amyotrophique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le syndrome de Guillain-Barré ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Department of Pathology (Neuropathology), University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Division of Neuromuscular Diseases, Neuropathology Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Human Performance Laboratory, Schulthess Clinic, Zurich, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Senior Consultant and Associate Professor of Neurology, Fortis Hospital, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Dean, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Manifestations neuromusculaires" :
There is a growing interest in personality evaluation in Parkinson's disease (PD), following observations of specific temperaments in PD patients. Therefore, our objective was to evaluate personality ...
Fluctuating PD patients from the PREDISTIM cohort were included. Description of TCI dimensions and comparison with a French normative cohort were performed. Pearson correlations between TCI dimensions...
The 570 PD patients presented significant higher scores in Harm Avoidance, Reward Dependence, Persistence, Self-Directedness and Cooperativeness and significant lower scores in Self-Transcendence comp...
The TCI seems to be an adequate tool to evaluate personality dimensions in PD with good structural and internal consistencies. These fluctuating PD patients also have specific personality dimensions c...
Inconsistent or careless responding is a significant threat to the validity of self-reported personality data. Using archival samples of undergraduate and community participants, we developed an incon...
The fifth edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-5; American Psychiatric Association, 2013) introduced the clinician-rated Levels of Personality Functioning Scale (...
This paper presents results of a study on the Polish adaptation of the Personality Inventory for ICD-11 (PiCD), which was developed to measure pathological traits under a new, dimensional model of per...
The study involved a non-clinical sample of N = 597 adults (51.4% female; Mage = 30.24 years; SD = 12.07 years). For convergent and divergent validity, Personality Inventory for DSM-5 (PID-5) and Big ...
The results showed the Polish adaptation of the PiCD to be reliable and valid. Cronbach's alpha coefficient for PiCD scale scores ranged from 0.77 to 0.87 (Mα = 0.82). The four-factor structure of PiC...
Obtained data demonstrate satisfactory internal consistency, factorial validity, and convergent-discriminant validity of the Polish adaptation of PiCD in a non-clinical sample....
Young adulthood has been recognized as an important period for the transition from adolescence to adulthood. The University Personality Inventory (UPI), a mental health questionnaire for young adultho...
Japanese medical students (n = 1185) participated in this study, and the UPI was completed at the time of university admission. The two-parameter IRT model was used to assess the measurement character...
Among all participants, 35.4% (420/1185) had total UPI score of 21 or more, and 10.6% (126/1185) indicated that they had the idea of wanting to die (item 25). For further IRT analysis, unidimensionali...
The UPI is useful to assess mild or moderate mental health problems, while precision may decline among individuals experiencing both little and extremely high levels of stress. Our findings provide a ...
The International Classification of Diseases 11th Revision (ICD-11) personality disorder model comprises, among other elements, five maladaptive personality trait domains (negative affectivity, detach...
The current study contributed to the validation of the PiCD validation by exploring its stability and predictive links with psychological distress over 6 months in a sample of 206 German community adu...
The PiCD trait domain scales displayed strong differential (all r ≥ .80) and absolute stability (all |d| ≤ .09). Additionally, PiCD negative affectivity predicted depression, anxiety, and stress, and ...
In sum, this study demonstrated the stability of the PiCD trait domain scores, supporting their utility for capturing relatively stable traits as described in the ICD-11. Additionally, we provided the...
In order to assess the internal consistency, fit indexes, test-retest reliability, and validity of the Personality Inventory for the DSM-5 (PID-5) and its associations with age, gender, and education,...
We found that; (a) temporal consistency of the Hungarian PID-5 was confirmed by one-month test-retest reliability analysis, (b) validity of the PID-5 instrument is acceptable in the clinical and the n...
These findings support that the Hungarian PID-5 is a reliable and valid instrument for both clinical and non-clinical populations....
The Personality Inventory for...
The relationship between maladaptive personality traits and psychotic disorders in the early stages of disease has not been thoroughly investigated, even though it is essential for developing preventi...
The five domains and the 25 facets of the Personality Inventory for DSM-5 (PID-5) were compared between 102 patients with recent-onset psychosis (ROP) and 116 community subjects (C) with a general lin...
Patients with ROP, compared to C, exhibited higher scores in four out of the five domains with medium effect sizes (Cohen's f...
Maladaptive personality traits were prominent in persons with ROP. These findings suggest that personality traits might play a role in vulnerability to psychosis and highlight the importance of evalua...
The current manuscript presents the convergence of the Dimensional Assessment of Personality Pathology (DAPP-BQ), using its short form the DAPP-90, and the Five-Factor Personality Inventory for Intern...